Everything (Maybe) You Wanted to Know About Sarilumab for PMR

(MedPage Today) -- Clinicians and others curious about the data underlying February's FDA approval of sarilumab (Kevzara) for polymyalgia rheumatica (PMR) can now be sated, at least partially, with publication today of the chief registration trial...
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news